Healio
Healio
Trial Scorecards Banner Image

Trial Scorecards
Issue: September 2013
September 01, 2013
1 min read
Save

AMPLIFY

Issue: September 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with acute venous thromboembolism were assigned 10 mg apixaban twice daily for 1 week followed by 5 mg twice daily for 6 months or conventional therapy consisting of enoxaparin followed by warfarin.

AMPLIFY

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.